Consult Duty Biochemist if the test is required for other than assessment of aluminium toxicity in dialysis patients.
Plasma Reference Intervals:
Normal Subjects: < 0.8 umol/L Patients with CRF on Aluminium Hydroxide therapy: 1.5—2.0 umol/L